Abstract
The receptor-like protein tyrosine phosphatase DEP1, also known as CD148, is expressed predominantly in epithelial cells, in a variety of tumor cell lines, and in lymphocytes. Expression of DEP1 is enhanced at high cell density, and this observation suggests that DEP1 may function in the regulation of cell adhesion and possibly contact inhibition of cell growth. In order to investigate the function of DEP1, substrate-trapping mutants of the phosphatase were used to identify potential substrates. GST-fusion proteins containing the DEP1 catalytic domain with a substrate-trapping D/A mutation were found to interact with p120ctn, a component of adherens junctions. DEP1 also interacted with other members of the catenin gene family including β-catenin and γ-catenin. The interaction with p120ctn is likely to be direct, as the interaction occurs in K562 cells lacking functional adherens junctions and E-cadherin expression. Catalytic domains of the tyrosine phosphatases PTP-PEST, CD45, and PTPβ did not interact with proteins of the catenin family to detectable levels, suggesting that the interaction of DEP1 with these proteins is specific. DEP1 expression was concentrated at sites of cell–cell contact in A549 cells. p120ctn was found to colocalize with these structures. Together these data suggest an important role for DEP-1 in the function of cell–cell contacts and adherens junctions.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Aicher B, Lerch MM, Muller T, Schilling J, Ullrich A . 1997 J. Cell Biol. 138: 681–696
Anastasiadis PZ, Moon SY, Thoreson MA, Mariner DJ, Crawford HC, Zheng Y, Reynolds AB . 2000 Nat. Cell Biol. 2: 634–637
Anastasiadis PZ, Reynolds AB . 2001 J. Cell Sci. 113: 1319–1334
Angers-Loustau A, Cote JF, Charest A, Dowbenko D, Spencer S, Lasky LA, Tremblay ML . 1999 J. Cell Biol. 144: 1019–1031
Aghib DF, McCrea PD . 1995 Exp. Cell Res. 218: 359–369
Baker JE, Majeti R, Tangye SG, Weiss A . 2001 Mol. Cell Biol. 21: 2393–2403
Barth AIM, Nathke IS, Nelson JW . 1997 Curr. Opin. Cell Biol. 9: 683–690
Behrens J, Vakaet L, Friis R, Winterhager E, Van Roy F, Mareel MM, Birchmeier W . 1993 J. Cell Biol. 120: 757–766
Brady-Kalnay SM, Rimm DL, Tonks NK . 1995 J. Cell Biol. 130: 986–997
Brady-Kalnay SM, Mourton T, Nixon JP, Pietz GE, Kinxh M, Chen H, Brackenbury R, Rimm DL, Del Vecchio RL, Tonks NK . 1998 J. Cell Biol. 141: 287–296
Calautti E, Cabodi S, Stein PL, Mechthild H, Kedersha N, Dotto PG . 1998 J. Cell Biol. 141: 1449–1465
Daniel JM, Reynolds AB . 1995 Mol. Cell Biol. 15: 4819–4824
Daniel JM, Reynolds AB . 1997 Bioessays 19: 883–891
de la Fuente-Garcia MA, Nicolas JM, Freed JH, Palou E, Thomas AP, Vilella R, Vives J, Gaya A . 1998 Blood 91: 2800–2809
Fachinger G, Urgan D, Risau W . 1999 Oncogene 18: 5948–5953
Flint AJ, Tiganis T, Barford D, Tonks NK . 1997 Proc. Natl. Acad. Sci. USA 94: 1680–1685
Fuchs MT, Muller T, Lerch MM, Ullrich A . 1996 J. Biol. Chem. 271: 16712–16719
Gaya A, Pirotto F, Palou E, Autschbach F, Del Pozo V, Sole J, Serra-Pages C . 1999 Leuk. Lymphoma 25: 237–243
Gumbiner BM . 1995 Curr. Opin. Cell Biol. 7: 634–640
Gumbiner BM . 1996 Cell 84: 345–357
Hamaguchi M, Matsuyoshi N, Ohnishi Y, Gotoh B, Takeichi M, Nagai Y . 1993 EMBO J. 12: 307–314
Jallal B, Mossie K, Vasiloudis G, Knyazev P, Zachwieja J, Clairvoyant F, Schilling J, Ullrich A . 1997 J. Biol. Chem. 272: 12158–12163
Keane MM, Lowrey GA, Ettenberg SA, Dayton MA, Lipkowitz S . 1996 Cancer Res. 56: 4236–4243
Knudsen KA, Peralta-Soler A, Johnson KR, Wheelock MJ . 1995 J. Cell Biol. 130: 67–77
Kovalenko J, Denner K, Sandstrom J, Persson C, Gross S, Jandt E, Vilella R, Bohmer F, Ostman A . 2000 J. Biol. Chem. 275: 16219–16226
Kinch MS, Clark G, Der CJ, Burridge K . 1995 J. Cell Biol. 130: 461–471
Kypta RM, Su H, Reichardt LF . 1996 J. Cell Biol. 134: 1519–1529
Lampugnani MG, Corada M, Caveda L, Breviarioi F, Ayalon O, Geiger B, Dejana E . 1995 J. Cell Biol. 129: 203–217
Mariner DJ, Anastasiadis P, Keilhack H, Bohmer F-D, Wang J, Reynolds AB . 2001 J. Biol. Chem. 276: 28006–28013
Lampugnani MG, Corada M, Andriopoulou P, Esser S, Risau W, Dejana E . 1997 J. Cell Sci. 110: 2065–2077
Matsuyoshi N, Hamaguchi M, Taniguchi S, Nagafuchi A, Tsukita S, Takeichi M . 1992 J. Cell Biol. 118: 703–714
Nagafuchi A, Takeichi M, Tsukita S . 1991 Cell 65: 849–857
Ostman A, Yang Q, Tonks NK . 1994 Proc. Natl. Acad. Sci. USA 91: 9680–9684
Osborne JM, den Elzen N, Lichanska AM, Costelloe EO, Yamada T, Cassady AI, Hume DA . 1998 J. Leukoc. Biol. 64: 692–701
Ozawa M, Kemler R . 1998 J. Biol. Chem. 273: 6166–6170
Pawlak G, Helfman DM . 2001 Curr. Opin. Gen. Dev. 11: 41–74
Reynolds AB, Roesel DJ, Kanner SB, Parsons JT . 1989 Mol. Cell. Biol. 9: 629–638
Reynolds AB, Daniel JM, McCrea PD, Wheelock MJ, Wu J, Zhang Z . 1994 Mol. Cell. Biol. 14: 8333–8342
Reynolds AB, Herbert L, Cleveland JL, Berg ST, Gaut JR . 1992 Oncogene 7: 2439–2445
Rimm DL, Koslov ER, Kebriaci P, Cianci CD, Morrow JS . 1995 Proc. Natl. Acad. Sci. USA 92: 8813–8817
Shiozaki H, Oka H, Inoue M, Tamura S . 1996 Cancer 77: 1605–1613
Sorby M, Sandstrom J, Ostman A . 2001 Oncogene 20: 5219–5224
Stuckey JA, Schuber HL, Fauman EB, Zhang ZY, Dixon JE, Saper MA . 1994 Nature (London) 370: 571–575
Staddon JM, Smales C, Schulze C, Esch FS, Rubin LL . 1995 J. Cell Biol. 130: 369–381
Takahashi T, Takahashi K, Mernaugh R, Drozdoff V, Sipe C, Schoecklmann H, Robert B, Abrahamson DR, Daniel TO . 1999 J. Am. Soc. Nephrol. 10: 2135–2145
Tangye SC, Wu J, Aversa G, de Vries JH, Lanier LL, Phillips JH . 1998a J. Immunol. 161: 3803–3807
Tangye SC, Phillips JH, Lanier LL, de Vries JH, Aversa G . 1998b J. Immunol. 161: 3249–3255
Zhang ZY, Wang Y, Dixon JE . 1994 Proc. Natl. Acad. Sci. USA 91: 1624–1627
Zondag GCM, Reynolds AB, Moolenaar WH . 2000 J. Biol. Chem. 275: 11264–11269
Acknowledgements
We thank Antoni Gaya and Eduard Palou for their kind gift of DEP1 143-41 antibody, and David Rimm for the p120ctn cDNA clone. We gratefully acknowledge Ron Hill, David Markby, and Audie Rice for comments on the manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Holsinger, L., Ward, K., Duffield, B. et al. The transmembrane receptor protein tyrosine phosphatase DEP1 interacts with p120ctn. Oncogene 21, 7067–7076 (2002). https://doi.org/10.1038/sj.onc.1205858
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1205858
Keywords
This article is cited by
-
The protein tyrosine phosphatase DEP-1/PTPRJ promotes breast cancer cell invasion and metastasis
Oncogene (2015)
-
Differential expression of CD148 on leukocyte subsets in inflammatory arthritis
Arthritis Research & Therapy (2013)
-
Not so simple: the complexity of phosphotyrosine signaling at cadherin adhesive contacts
Journal of Molecular Medicine (2007)
-
The rat tyrosine phosphatase η increases cell adhesion by activating c-Src through dephosphorylation of its inhibitory phosphotyrosine residue
Oncogene (2005)
-
G1 checkpoint failure and increased tumor susceptibility in mice lacking the novel p53 target Ptprv
The EMBO Journal (2005)